Burden of bladder cancer across Asia: Insights from the Global Burden of Disease (1999–2023).
Abstract
e16617 Background: Bladder cancer is a malignant neoplasm arising from uncontrolled growth of the urothelial lining and represents an increasing global health concern. This study examines long-term trends in disability-adjusted life years (DALYs) and mortality due to bladder cancer across Asia from 1990 to 2023. Methods: Age-standardized bladder cancer data were obtained from the Global Burden of Disease (GBD) database. Mortality was reported as age-standardized death rates (ASDRs) per 100,000 population. Temporal trends were assessed using joinpoint regression to estimate annual percentage change (APC) and average annual percentage change (AAPC). Results: From 1990 to 2023, age-standardized DALYs declined across most Asian regions. East Asia carried the highest burden but showed a marked reduction, with DALYs decreasing from 70.38 to 40.42 (AAPC −1.59%; 95% CI −2.27 to −0.90; p < 0.001). Significant declines were also observed in Central Asia (57.34 to 40.10; AAPC −1.10%; p = 0.020) and High-income Asia Pacific (49.51 to 43.00; AAPC −0.44%; p < 0.001). South Asia demonstrated only a modest decrease (31.78 to 30.68; AAPC −0.17%; p = 0.042), while Southeast Asia remained relatively stable (26.30 to 28.60; AAPC 0.24%; p = 0.16). ASDRs showed similar patterns. East Asia had the highest mortality rates, declining from 3.20 to 2.03 per 100,000 (AAPC −1.03%; p < 0.001). Central Asia and High-income Asia Pacific also experienced significant reductions, whereas South and Southeast Asia exhibited largely stable trends. Conclusions: Although bladder cancer burden has declined across much of Asia, mortality and DALYs remain substantial. Strengthening early detection, risk-factor control, and preventive strategies remains essential to further reduce disease impact. Trends in bladder cancer burden across Asia (1990–2023). Region DALYs 1990 DALYs 2023 AAPC (%) ASDR trend East Asia 70.38 40.42 −1.59 ↓ Central Asia 57.34 40.10 −1.10 ↓ High-income Asia Pacific 49.51 43.00 −0.44 ↓ South Asia 31.78 30.68 −0.17 ↔ Southeast Asia 26.30 28.60 +0.24 ↔ DALYs and ASDRs are age-standardized per GBD 2023. ↓ indicates significant decline; ↔ indicates stable trend.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (10)
Areesha Mansoor
Dow university of health sciences, Karachi , Pakistan
Sarim Hassan Shahab
Nishtar Medical University, Multan, Punjab, Pakistan
Sanhia Maheshwari
Jinnah Sindh Medical University, Karachi, Pakistan
FNU Sawaira
5Peshawar Girls Medical College, Peshawar, Peshawar, Pakistan
Owais Gul
United Health Services Hospitals, Johnson City, NY
Muhammad Yasir
Aizaz Ali
Aizaz Anwar Khalid
Peshawar Medical College, Swabi, Pakistan
Huzaifa Sabir Nawaz
Services Institute of Medical Sciences, Lahore, Pakistan
Syeda Malika Naqvi
Nishtar Medical University, Multan, Pakistan